<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[HOYA Vision Care 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=48245></link><description><![CDATA[HOYA Vision Care 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 02 May 2026 06:36:33 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2025/06/12_1028147215_20250615135035_5680108449.png]]></url></image><language>ko-KR</language><item><title><![CDATA[HOYA Vision Care Unveils Updates from the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1013114</link><description><![CDATA[SALT LAKE CITY--(Business Wire/Korea Newswire)--HOYA Vision Care  today announced  new clinical evidence from three key clinical studies highlighting the impact of Defocus Incorporated Multiple Segments (D.I.M.S.) Technology. The results were presented  as part of the company’s 2025 scientific program, Exploring New Frontiers in Myopia Management with MiYOSMART*, at the Association for Resear...]]></description><pubDate>Sun, 15 Jun 2025 14:10:00 +0900</pubDate></item><item><title><![CDATA[호야 비전 케어, 시력및안과연구협회(ARVO) 2025 연례 회의 업데이트 발표]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1013115</link><description><![CDATA[솔트 레이크 시티--(Business Wire/뉴스와이어)--호야 비전 케어(HOYA Vision Care)가 오늘 D.I.M.S(Defocus Incorporated Multiple Segments)의 영향을 강조하는 세 가지 주요 임상 연구의 새로운 임상 증거를 발표했다 . 이 결과는 미국 유타주 솔트레이크시티의 열린 시력및안과연구협회(Association for Research in Vision and Ophthalmology, ARVO) 2025 연례 회의에서 회사의 2025년 과학 프로그램인 MiYOSMART*를 ...]]></description><pubDate>Sun, 15 Jun 2025 14:10:00 +0900</pubDate></item></channel></rss>